STANGA Paulo E.

Medical & Surgical Retina, Cataract Surgery, Eye Trauma R&D New Therapies, Imaging, Laser & Surgical Tech. Consultant Ophthalmologist and Lead Vitreoretinal Surgeon for the Manchester Royal Eye Hospital and Professor of Ophthalmology and Retinal Regeneration for the University of Manchester.

Prof. Paulo E. Stanga is a Consultant Ophthalmologist and Vitreoretinal Surgeon for the Manchester Royal Eye Hospital and Professor of Ophthalmology and Retinal Regeneration for the University of Manchester. Previous appointments: Lecturer in Ophthalmology for the University of Liverpool, Vitreoretinal Fellow at the Royal Liverpool University Hospital, Medical Retina Fellow at Moorfields Eye Hospital and Retina Research Fellow, New York Hospital, Cornell University Medical College, New York, USA.

Prof. Stanga is Director of the Manchester Vision Regeneration (MVR) Lab at NIHR/Wellcome Trust Manchester CRF and its Retinal Clinical-Research Fellowship Program, MREH Lead for the Retinal Laser Service, MREH and University of Manchester Laser Safety Representative, Chairman of the MREH Research Steering Committee, President of the Ophthalmic Imaging Association and Member of the Scientific Committee of the Royal College of Ophthalmologists.

Since 1993, Prof. Stanga has worked in the development and application of new outpatient and surgical therapies and technologies. Current research interests are: vitreo-retinal imaging, pharmacological, surgical and laser treatment of proliferative diabetic retinopathy and macular oedema, laser-tissue interaction, development of vitrectomy equipment, electronic retinal implants for artificial vision and stem-cell therapy.

Prof. Stanga has set up and directs an independent Clinical Research Fellowship Program at the Manchester Royal Eye Hospital and MVR Lab. The MVR Lab research team focus on developing research and treatment stategies in Medical Retina and Vitreoretinal conditions using the most advanced diagnostic and treatment devices.

Prof. Stanga has received several international accolades, amongst others, the prestigious Achievement Award by American Academy Of Ophthalmology (AAO) for his regular contributions to its Annual Meeting.
Prof. Stanga introduced, amongst others, OCT into the clinical setting in the UK in 1998, Pascal Laser into the EU in 2006 and has also pioneered Swept-Source OCT, having introduced it into the EU in 2012, and Optos Wide-Field imaging and Optos-guided tissue-sparing laser treatment strategies.